| Considerable escape of SARS-CoV-2 Omicron to antibody neutralization D Planas, N Saunders, P Maes, F Guivel-Benhassine, C Planchais, ... Nature 602 (7898), 671-675, 2022 | 1455 | 2022 |
| SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation MM Rajah, M Hubert, E Bishop, N Saunders, R Robinot, L Grzelak, ... The EMBO journal 40 (24), e108944, 2021 | 170 | 2021 |
| A nanoprimer to improve the systemic delivery of siRNA and mRNA NRM Saunders, MS Paolini, OS Fenton, L Poul, J Devalliere, F Mpambani, ... Nano Letters 20 (6), 4264-4269, 2020 | 61 | 2020 |
| TMPRSS2 is a functional receptor for human coronavirus HKU1 N Saunders, I Fernandez, C Planchais, V Michel, MM Rajah, ... Nature 624 (7990), 207-214, 2023 | 17 | 2023 |
| Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY. 4.2 N Saunders, D Planas, WH Bolland, C Rodriguez, S Fourati, J Buchrieser, ... EBioMedicine 77, 2022 | 13 | 2022 |
| The spike-stabilizing D614G mutation interacts with S1/S2 cleavage site mutations to promote the infectious potential of SARS-CoV-2 variants S Gellenoncourt, N Saunders, R Robinot, L Auguste, MM Rajah, ... Journal of Virology 96 (19), e01301-22, 2022 | 12 | 2022 |
| Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus I Fernandez, N Saunders, S Duquerroy, WH Bolland, A Arbabian, ... bioRxiv, 2024.02. 21.581378, 2024 | 1 | 2024 |
| Dynamic label-free analysis of SARS-CoV-2 infection reveals virus-induced subcellular remodeling N Saunders, B Monel, N Cayet, L Archetti, H Moreno, A Jeanne, ... Nature Communications 15 (1), 4996, 2024 | | 2024 |
| TMPRSS2 is the receptor of seasonal coronavirus HKU1 N Saunders, O Schwartz Medecine Sciences: M/S 40 (4), 335-337, 2024 | | 2024 |
| TMPRSS2 est le récepteur cellulaire du coronavirus saisonnier HKU1 N Saunders, O Schwartz médecine/sciences 40 (4), 335-337, 2024 | | 2024 |
| The Nanoprimer: a nanoparticle designed to transiently occupy the mononuclear phagocytic system in order to increase nanomedicine-based treatments efficacy J Devalliere, L Poul, A Darmon, O Jibault, M Bergere, F Mpambani, ... Cancer Research 80 (16_Supplement), 2871-2871, 2020 | | 2020 |
Ludivine GrzelakInstitut Pasteur在 pasteur.fr 的电子邮件经过验证
